LINDSEY BOOKHARDT: Open Payments
NPI 1942279294 · JESUP, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 20 payments from 10 companies in 2025. Trend: 2023 $25 · 2024 $382 · 2025 $640
Food & beverage: $444Education: $196
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $258 |
| Janssen Biotech, Inc. | 2 | $123 |
| UCB, Inc. | 3 | $89 |
| Organon LLC | 1 | $35 |
| ABBVIE INC. | 1 | $33 |
| PFIZER INC. | 1 | $32 |
| Amgen Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: DUPIXENT, TREMFYA, Bimzelx, VTAMA, RINVOQ, CIBINQO, Otezla, TALTZ.
Industry payments across GA — which companies pay providers there.
